Hepatitis C virus infection

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Structural biology of hepatitis C virus
R. Cavallo  Clinical Microbiology and Infection 
Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013  J. Verschueren, L. Cnops,
Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines.
L. Boyanova  Clinical Microbiology and Infection 
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Gut bacterial microbiota and obesity
Human papilloma viruses and cancer in the post-vaccine era
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Infectious causes of cancer: an evolving educational saga
Virological tools to diagnose and monitor hepatitis C virus infection
R. Cantón  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Non-antibiotic strategies for sepsis
Evaluation of viral co-infections in hospitalized and non-hospitalized children with respiratory infections using microarrays  S. Kouni, P. Karakitsos,
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Emerging Therapeutic Targets for Hepatitis C Virus Infection
Vector control: a cornerstone in the malaria elimination campaign
Molecular mechanism of gentamicin resistance in Bartonella henselae
Volume 44, Issue 2, Pages (February 2006)
Training for the infectious diseases speciality in Norway
Disruption of the interactions between the subunits of herpesvirus DNA polymerases as a novel antiviral strategy  A. Loregian, G. Palù  Clinical Microbiology.
Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels  B. Sarov, L. Novack, N.
B. Gordts  Clinical Microbiology and Infection 
Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Occupational transmission of hepatitis C virus resulting from use of the same supermarket meat slicer  L. Bocket, S. Chevaliez, N. Talbodec, A. Sobaszek,
F. Magurano  Clinical Microbiology and Infection 
Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and western European influences  C.M. Olinger, N.V.
V Duque, ÁA. Holguín, M. Silvestre, J. GonzÁAlez-Lahoz, V. Soriano 
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Hepatitis B and C virus-related carcinogenesis
Previously unknown species of Aspergillus
T.M. File  Clinical Microbiology and Infection 
New developments in laboratory monitoring of HIV-1 infection
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
New therapies on the horizon for hepatitis C
Abstracts cont. Clinical Microbiology and Infection
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Vaccinations against respiratory tract infections at Hajj
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains  P. Trémeaux, A. Caporossi,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
Virology: a scientific discipline facing new challenges
Plague in the genomic area
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Simplified overview of the HCV life cycle and sites of direct acting antiviral therapies. Simplified overview of the HCV life cycle and sites of direct.
J.L. Balcázar  Clinical Microbiology and Infection 
Sandfly fever virus outbreak in Cyprus
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Hepatitis C virus infection B.J. Thomson, R.G. Finch  Clinical Microbiology and Infection  Volume 11, Issue 2, Pages 86-94 (February 2005) DOI: 10.1111/j.1469-0691.2004.01061.x Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 The structure of the hepatitis C virus genome [7]. The 5’ non-coding region (NCR) contains four highly conserved RNA domains and an internal ribosome entry site. Structural proteins include core, which forms the virus capsid, and the envelope glycoproteins E1 and E2. The structural proteins are separated from the non-structural (NS) proteins by a short peptide, P7 (not shown). NS proteins are designated NS2 to NS5. NS4 and NS5 are each processed further into two subunits, A and B. NS2 is a component of the NS2–NS3 metalloprotease that autocatalyses cleavage of the NS2–NS3 junction; NS3 contributes to the NS2–NS3 protease and contains a separate serine protease that acts with co-factor NS4A to release the remaining NS proteins. The C-terminal region of NS3 contains an RNA helicase and nucleotide triphosphatase activity required for virus replication. NS5B is the RNA-dependent RNA polymerase. The functions of NS4B and NS5A in the virus life-cycle are unknown. The 3'-NCR contains a series of stable RNA stem–loop structures and a polypyrimidine tract that is essential for genome replication. Clinical Microbiology and Infection 2005 11, 86-94DOI: (10.1111/j.1469-0691.2004.01061.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions